Home
       
STOCK MARKETS


Back

10 Last viewed shares   
 
Business Segments
  Business Segments
  ACTIVITIES REVIEW The Group is principally engaged in RD and commercialization of innovative drugs. On RD, the Group is committed to developing four RD ...
  Read more... 
Year in Brief
  Year in Brief
  2014 Main Highlights January Launched renal anemia treatment NESP ® Injection 5μg Plastic Syringe in Japan February Added new information covering pollinosis ...
  Read more... 
Company Presentation
  Company Presentation
  Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in ...
  Read more... 
   

Biotest AG

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
Biotest St. (XETRA)‎  
Last 42,00      Change % 0,00 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 17:36:26
Last 42,00
Change % 0,00 
Change 0,00 
Bid/Ask 41,80 / 43,00
Open 41,60
High/Low 42,00 / 41,60
Volume 30
Previous Close 42,00
52 Weeks High 44,00
52 Weeks Low 39,60
52 Weeks %   -0,95 
YTD %   -1,41 
Volatility N/A
Beta N/A
Correlation N/A
MARKET DATA
Symbol BIO
Market  XETRA
List  Prime Standard
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Pharmaceuticals manufactures
Shares (mil)1 39,57
Market Cap (mil) 1 662,00
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 Prime All Share
 

Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024